For invoicing options, please email:
The Medical Imaging Bundle includes the following reports at a 15% discount off the individual reports being purchased separately:
• Mammography World Markets.
• Medical Imaging Markets.
• Nuclear Cardiology Markets.
• Picture Archiving and Communications Systems (PACS).
• Positron Emission Tomography (PET) Markets.
• Ultrasound Markets.
 View Sample PDF
The women's mammography segment is poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital areas and the higher interest of individual patients and general healthcare consumers to take charge of their own health status. Continuous improvements in technology are resulting in a growing number of new imaging diagnostic tests that combine high levels of accuracy with rapid, easy-to-use product formats. Digital mammography is driving more screening programs. The emphasis in this TriMark Publications report is on those companies and products that are actively developing and marketing clinical laboratory instrumentation and reagents and supplies for performing diagnostic tests on conditions specifically related to women's health. This study concentrates on the mammography market segment in large worldwide markets such as the U.S., Japan and Europe. Certain areas that are not covered include what is generally characterized as digital imaging techniques instruments and reagents, PACS or other data storage methods, or other medical imaging technologies, although many of the instruments, reagents and techniques in the mammography market segment are intimately associated with these broader areas. Specialty areas in medical imaging are touched upon, since these segments are frequently a part of the overall analytical focus of companies marketing general mammography equipment. However, no effort is made to quantify the size of this broader market.
View Sample PDF
There will be a steady increase in demand for medical imaging services, along with pressures to improve the quality of healthcare delivered in the home and to lower its cost. The medical imaging segments are poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital information technology segment, and the higher interest of individual older baby boom patients and general healthcare consumers to monitor health status. Continuous improvements in technology are resulting in a growing number of new imaging tests that combine high levels of accuracy with rapid, easy-to-use product formats. Digital mammography is driving more screening programs. The purpose of this TriMark Publications report is to describe the specific market segment of the diagnostics market sector called medical imaging. This sector includes all of the generally-accepted imaging activities that are currently used today, including X-ray and radiography, mammography, magnetic resonance imaging (MRI), ultrasound, gamma camera market, computed tomography (CT) scans and positron emission tomography (PET) scans. It examines these clinical measurement devices and their reagents and supplies as used in hospitals, clinics and doctor's offices. It also includes associated market segments like picture archiving and communications system (PACS) markets, cardiology imaging markets, three-dimensional (3D) imaging markets and other emerging technologies.
View Sample PDF
The purpose of this TriMark Publications report is to analyze and describe the nuclear cardiology market segments in the U.S. and worldwide. It examines the measurement devices that are utilized by physicians to diagnose and monitor heart diseases. This study also discusses key products in nuclear cardiology and examines the trends that are stimulating this market. It includes a survey of all major companies actively engaged in marketing, manufacturing or developing nuclear cardiological instrumentation, with each company discussed in depth. The main objectives of this analysis are to: 1) identify viable technology drivers through a comprehensive look at platform technologies for nuclear cardiology testing; 2) obtain a complete understanding of the individual nuclear cardiology testing platforms from their basic principles to their clinical applications; 3) discover feasible market opportunities by identifying high-growth applications in different clinical diagnostic areas; 4) focus on global industry developments through an in-depth analysis of the major world markets for nuclear cardiology technology, including growth forecasts; and 5) present market figures related to the current value of nuclear cardiology, market projections, market share, key players, and sector growth rates.
View Sample PDF
During the past 35 years, ultrasound and nuclear medicine were introduced into clinical medicine, computed tomography (CT) revolutionized diagnostic procedures and magnetic resonance imaging (MRI) emerged, bringing new diagnostic information at the cellular level. X-ray morphed from analog films to digital, and virtually all medical images became "soft" files on the electronic networks. As imaging departments in healthcare facilities have migrated from film to digital, the display and storage systems have had to migrate too. These new digital imaging storage and display systems are called picture archiving and communication systems (PACS). Most PACSs handle images from various medical imaging instruments, including ultrasound, MRI, positron emission tomography (PET), CT, endoscopy, mammograms, etc. The focus of this TriMark Publications report is to analyze and describe the PACS market segments. PACS market penetration in the U.S. healthcare space has been significant, at almost 90%. A PACS network typically consists of a central server that stores a database containing the images connected to one or more clients via a local area network (LAN) or a wide area network (WAN) that provides or utilizes the images. More and more PACS utilize Internet-based technologies as their means of communication. This allows remote viewing and diagnosis with implications for both civilian and military healthcare facilities. Since radiology departments dominate the production of images, interconnections with radiology information systems (RIS) are also looked at in this study.
View Sample PDF
The medical imaging segments are poised for a major new phase of growth fueled by the availability of new technology coming out of the computer and digital information technology segment. Continuous improvements in technology are resulting in a growing number of new imaging tests that combine high levels of accuracy with rapid, easy-to-use product formats. Part of that medical imaging improvement is coming from positron emission tomography (PET). PET is a scanning technique used in combination with small amounts of radio-labeled compounds to visualize the anatomy and function of the brain. The purpose of this TriMark Publications report is to describe the specific market segment of the diagnostics medical imaging market called PET scanning. This sector includes all of the generally accepted imaging activities that are currently used in PET, including equipment for PET, PET/CT, SPECT and the use of radiopharmaceuticals for imaging. It examines these clinical measurement devices and their reagents and supplies as used in hospitals and clinics. It also reviews associated clinical market segments in which PET scanning has taken a prominent role including cancer treatment, cardiology and neurology imaging markets.
View Sample PDF
During the past 35 years, ultrasound and nuclear medicine were introduced into clinical medicine, computed tomography (CT) revolutionized diagnostic procedures and magnetic resonance imaging (MRI) emerged, bringing new diagnostic information at the cellular level. X-ray morphed from analog films to digital, and virtually all medical images became "soft" files on the electronic superhighway. This TriMark Publications report describes the increasingly diversified market segment of the diagnostics market sector called ultrasonography or, more commonly, ultrasound. This sector currently includes prenatal ultrasonography, cardiac and cardiology-imaging ultrasound, and increasingly portable or handheld ultrasound, which some believe may partly to fully replace the ubiquitous use of stethoscopes over time. Emerging market segments such as three-dimensional (3D) and now four-dimensional (4D) ultrasound are also examined.
For invoicing options, please email:
| 
